[Clinico-morphological comparisons in pulmonary tuberculosis of patients with toxico-allergic reactions]. 1974

L K Bogush, and A A Lesnaia, and T A Akmatov

UI MeSH Term Description Entries
D008297 Male Males
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

L K Bogush, and A A Lesnaia, and T A Akmatov
January 1968, Problemy tuberkuleza,
L K Bogush, and A A Lesnaia, and T A Akmatov
October 1965, Sovetskaia meditsina,
L K Bogush, and A A Lesnaia, and T A Akmatov
January 2011, Vestnik khirurgii imeni I. I. Grekova,
L K Bogush, and A A Lesnaia, and T A Akmatov
January 1973, Problemy tuberkuleza,
L K Bogush, and A A Lesnaia, and T A Akmatov
March 1977, Problemy tuberkuleza,
L K Bogush, and A A Lesnaia, and T A Akmatov
January 1969, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
L K Bogush, and A A Lesnaia, and T A Akmatov
February 1978, Problemy tuberkuleza,
L K Bogush, and A A Lesnaia, and T A Akmatov
January 1975, Problemy tuberkuleza,
L K Bogush, and A A Lesnaia, and T A Akmatov
January 1984, Sovetskaia meditsina,
L K Bogush, and A A Lesnaia, and T A Akmatov
January 1989, Gigiena truda i professional'nye zabolevaniia,
Copied contents to your clipboard!